Published in Blood on June 01, 1966
Radioautography with tritiated thymidine in measles and Sendai virus-induced chromosome pulverizations. J Cell Biol (1967) 0.83
Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and mutagenesis of herpes simplex virus type 1. Antimicrob Agents Chemother (1986) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med (2000) 5.43
CELLULAR PROLIFERATION IN THE MOUSE AS REVEALED BY AUTORADIOGRAPHY WITH TRITIATED THYMIDINE. Proc Natl Acad Sci U S A (1958) 5.33
Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03
Platelet counts with the Coulter counter. Am J Clin Pathol (1965) 4.07
Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet (1966) 3.26
Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) (1977) 3.20
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol (1988) 2.60
Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int J Cancer (1966) 2.51
Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Stability of blood in commonly used anticoagulants. Use of refrigerated blood for quality control of the Coulter Counter Model S. Am J Clin Pathol (1969) 2.07
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
A comparative analysis of pulmonary perfusion scans with pulmonary angiograms. Am Heart J (1976) 1.93
Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) (1981) 1.88
Present status of spiculed red cells and their relationship to the discocyte-echinocyte transformation: a critical review. Blood (1972) 1.85
Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83
Current concepts: guidelines for the use of thrombolytic agents. N Engl J Med (1979) 1.82
Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol (1978) 1.79
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79
The clinical features of submassive and massive pulmonary emboli. Am J Med (1977) 1.77
Angiosarcoma of the liver following vinyl chloride exposure. JAMA (1974) 1.77
Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
Letter: Dilantin, agranulocytosis, and phagocytic marrow histiocytes. Ann Intern Med (1976) 1.63
Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58
An evaluation of the relative merits of the Wintrobe and Westergren sedimentation methods, including hematocrit correction. Am J Clin Pathol (1974) 1.56
Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). Cancer Chemother Rep (1970) 1.55
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer (1984) 1.54
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med (1975) 1.53
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50
Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med (1976) 1.46
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
Acetaminophen and warfarin: undesirable synergy. JAMA (1998) 1.43
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J (2003) 1.41
Rectal abscesses in cancer patients. Lancet (1972) 1.40
Immunologic reactivity in patients with leprosy. Ann Intern Med (1969) 1.39
The effect of arvin on blood coagulation factors. Br J Haematol (1968) 1.39
Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med (1985) 1.38
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis. Br Med J (1966) 1.34
Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34
Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34
Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J (1982) 1.34
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst (1972) 1.32
Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J Biol Chem (1982) 1.32
Reticuloendothelial system phagocytic function in patients with Hodgkin's disease. J Clin Invest (1967) 1.30
Controlled studies in clinical cancer research. N Engl J Med (1972) 1.30
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27
Short- and long-term repopulation of lethally irradiated mice by bone marrow stem cells enriched on the basis of light scatter and Hoechst 33342 fluorescence. Exp Hematol (1991) 1.27
Effects of bacterial endotoxin on the occurrence of spleen colonies in irradiated mice. Radiat Res (1966) 1.27
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26
Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci U S A (1982) 1.25
Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer (1971) 1.25
Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med (1967) 1.25
Hospital-acquired salmonellosis traced to carmine dye capsules. N Engl J Med (1967) 1.24
Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest (1972) 1.22
Basal cell nevus syndrome. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1966) 1.20
Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. Science (1985) 1.19
Bone marrow transfusions in previously irradiated, hematologically normal syngeneic mice. Proc Soc Exp Biol Med (1981) 1.18
Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res (1968) 1.16
Central nervous system involvement in Burkitt's lymphoma. Blood (1970) 1.16
Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence. J Biol Chem (1985) 1.16
The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients. Ann Intern Med (1979) 1.16
Lactic acidosis in malignancy and observations on its possible pathogenesis. Ann N Y Acad Sci (1974) 1.16
Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia. Blood (1978) 1.15
The health consequences of smoking. Cancer. Med Clin North Am (1992) 1.15
Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer (1983) 1.14
Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood (1971) 1.14
Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland. Eur J Cancer (1978) 1.13
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer (1978) 1.13
Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem (1988) 1.12
Antidiuretic response to cyclophosphamide in man. J Pharmacol Exp Ther (1973) 1.12
A lesson from the mammography issue. Ann Intern Med (1978) 1.11
Lymphoma of the breast. Ann Surg (1981) 1.11
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. Cancer Res (1965) 1.08
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem (1982) 1.07
Acetohydroxamate: bacterial urease inhibitor with therapeutic potential in hyperammonaemic states. Nature (1965) 1.07
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.07
Disseminated intravascular coagulation. Johns Hopkins Med J (1980) 1.06